0% found this document useful (0 votes)
72 views1 page

COVID-19 Positive PCR Test Report

Uploaded by

Anubhav Gupta
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
72 views1 page

COVID-19 Positive PCR Test Report

Uploaded by

Anubhav Gupta
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd

SRF ID: 0708201671393

Lab No. 012201101306 Age/Gender 25 YRS/Male Coll. On 10/Jan/2022 06:23PM


Name Mr. ANUBHAV GUPTA Reg. On 10/Jan/2022
Ref. Dr. DGD ASHOK VIHAR Approved On 11/Jan/2022 12:00AM
Rpt. Centre Self Printed On 11/Jan/2022 12:18PM

Test Name Value Unit Biological Reference


Interval

COVID-19 Virus QUALITATIVE PCR *, swab POSITIVE Please refer the table below
Method : RT PCR
N1/RdRp/ORF1 gene CT value 28
N2/N gene CT value 27
Address:54 SAMRAT ENCLAVE DELHI 34 Pin:110034, Mobile:9810369303

Interpretation:
Result Remarks
Positive SARS-CoV-2 (COVID-19) specific RNA detected
Only B-βCoV specific RNA detected. This might be due to low viral load or due to
Presumptive mutation in the SARS-CoV-2 (COVID-19) specific RNA.
Positive All presumptive positive reports are released only after re-extracting the RNA and
performing a repeat RT-PCR.
Negative RNA specific to B-βCoV and SARS-CoV-2 (COVID-19) not detected
This could be due to presence of inhibitors in the sample. A repeat sample is
recommended in such cases.
Inconclusive
All inconclusive reports are released only after re-extracting the RNA and performing
a repeat RT-PCR.

Note:
1. ICMR Registration number for Covid -19 is PROGD001.
2. Negative result does not rule out the possibility of Covid-19 infection. Presence of inhibitors, mutations & insufficient RNA specific to SARS-CoV-2 can influence the
test result. Kindly correlate the results with clinical findings. A negative result in a single upper respiratory tract sample does not rule out SARS-CoV-2 infection. Hence in
such cases a repeat sample should be sent. Lower respiratory tract samples like Sputum, BAL, ET aspirate are appropriate samples especially in severe and progressive lung
disease.
3. Covid-19 Test conducted as per kits approved by ICMR / CE-IVD / USFDA.
4. Kindly consult referring Physician / Authorized hospitals for appropriate follow up.
5. Test conducted on combined Oropharyngeal & nasal swabs

Comments: Coronaviruses (CoV) are a large family of viruses that cause illness ranging from the common cold to more severe diseases such as Middle East Respiratory
Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV). Coronavirus disease (COVID-19) is a new strain that was discovered in 2019 and has not
been previously identified in humans. Common signs of infection include respiratory symptoms, fever, cough, shortness of breath and breathing difficulties. In more severe
cases, infection can cause pneumonia, severe acute respiratory syndrome and kidney failure

*** End Of Report ***

Scan this QR Code to view report


Page 1 of 1

You might also like